Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the npde add-on package for R
- PMID: 18215437
- DOI: 10.1016/j.cmpb.2007.12.002
Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the npde add-on package for R
Abstract
Pharmacokinetic/pharmacodynamic data are often analysed using nonlinear mixed-effect models, and model evaluation should be an important part of the analysis. Recently, normalised prediction distribution errors (npde) have been proposed as a model evaluation tool. In this paper, we describe an add-on package for the open source statistical package R, designed to compute npde. npde take into account the full predictive distribution of each individual observation and handle multiple observations within subjects. Under the null hypothesis that the model under scrutiny describes the validation dataset, npde should follow the standard normal distribution. Simulations need to be performed before hand, using for example the software used for model estimation. We illustrate the use of the package with two simulated datasets, one under the true model and one with different parameter values, to show how npde can be used to evaluate models. Model estimation and data simulation were performed using NONMEM version 5.1.
Similar articles
-
[Comparison study of model evaluation methods: normalized prediction distribution errors vs. visual predictive check].Yao Xue Xue Bao. 2011 Sep;46(9):1123-31. Yao Xue Xue Bao. 2011. PMID: 22121786 Chinese.
-
Fisher information matrix for nonlinear mixed effects multiple response models: evaluation of the appropriateness of the first order linearization using a pharmacokinetic/pharmacodynamic model.Stat Med. 2009 Jun 30;28(14):1940-56. doi: 10.1002/sim.3573. Stat Med. 2009. PMID: 19266541
-
Non-linear mixed-effects pharmacokinetic/pharmacodynamic modelling in NLME using differential equations.Comput Methods Programs Biomed. 2004 Oct;76(1):31-40. doi: 10.1016/j.cmpb.2004.01.001. Comput Methods Programs Biomed. 2004. PMID: 15313540
-
Developing Tools to Evaluate Non-linear Mixed Effect Models: 20 Years on the npde Adventure.AAPS J. 2021 May 19;23(4):75. doi: 10.1208/s12248-021-00597-7. AAPS J. 2021. PMID: 34009502 Review.
-
Approaches to simultaneous analysis of frequency and severity of symptoms.Clin Pharmacol Ther. 2010 Aug;88(2):255-9. doi: 10.1038/clpt.2010.118. Epub 2010 Jul 7. Clin Pharmacol Ther. 2010. PMID: 20613722 Review. No abstract available.
Cited by
-
Population Pharmacokinetic Study of Cefathiamidine in Infants With Augmented Renal Clearance.Front Pharmacol. 2021 Mar 15;12:630047. doi: 10.3389/fphar.2021.630047. eCollection 2021. Front Pharmacol. 2021. PMID: 33790793 Free PMC article.
-
Population pharmacokinetics of clindamycin orally and intravenously administered in patients with osteomyelitis.Br J Clin Pharmacol. 2012 Dec;74(6):971-7. doi: 10.1111/j.1365-2125.2012.04292.x. Br J Clin Pharmacol. 2012. PMID: 22486719 Free PMC article.
-
Influence of FCGR3A-158V/F Genotype and Baseline CD20 Antigen Count on Target-Mediated Elimination of Rituximab in Patients with Chronic Lymphocytic Leukemia: A Study of FILO Group.Clin Pharmacokinet. 2017 Jun;56(6):635-647. doi: 10.1007/s40262-016-0470-8. Clin Pharmacokinet. 2017. PMID: 27783363 Clinical Trial.
-
Population pharmacokinetics of losmapimod in healthy subjects and patients with rheumatoid arthritis and chronic obstructive pulmonary diseases.Clin Pharmacokinet. 2013 Mar;52(3):187-98. doi: 10.1007/s40262-012-0025-6. Clin Pharmacokinet. 2013. PMID: 23254770 Clinical Trial.
-
Model-based prediction of the acute and long-term safety profile of naproxen in rats.Br J Pharmacol. 2015 Aug;172(15):3861-74. doi: 10.1111/bph.13167. Epub 2015 Jun 29. Br J Pharmacol. 2015. PMID: 25884765 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources